Fieldpoint Private Securities’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$134K Sell
6,453
-248
-4% -$5.11K 0.04% 310
2022
Q1
$152K Buy
6,701
+25
+0.4% +$488 0.03% 354
2021
Q4
$122K Buy
6,676
+1,049
+19% +$20.1K 0.02% 401
2021
Q3
$119K Hold
5,627
0.03% 388
2021
Q2
$97K Sell
5,627
-333
-6% -$7.77K 0.02% 420
2021
Q1
$135K Sell
5,960
-1,577
-21% -$35.6K 0.03% 348
2020
Q4
$151K Buy
+7,537
New +$158K 0.03% 327
2020
Q2
Sell
-21,799
Closed -$375K 267
2020
Q1
$375K Buy
21,799
+341
+2% +$6.24K 0.14% 155
2019
Q4
$378K Buy
21,458
+13,159
+159% +$223K 0.11% 186
2019
Q3
$147K Sell
8,299
-718
-8% -$14.5K 0.05% 241
2019
Q2
$193K Buy
+9,017
New +$189K 0.06% 234

Other funds holding EXEL

Fieldpoint Private Securities's EXEL Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Exelixis (EXEL) stake by 3.7% in Q2 2022, selling an estimated $5.11K and leaving 6,453 shares worth $134K. The position accounts for 0.04% of the portfolio, ranked #310.

Fieldpoint Private Securities first reported a position in EXEL in Q2 2019 and has held it in 11 quarters since. The position peaked at $378K in Q4 2019. 375 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

  • Fieldpoint Private Securities held 6,453 shares of Exelixis worth $134K as of Q2 2022.
  • Fieldpoint Private Securities sold 248 Exelixis shares in Q2 2022, an estimated $5.11K.
  • Exelixis made up 0.04% of Fieldpoint Private Securities's portfolio in Q2 2022, its #310 holding.
  • Fieldpoint Private Securities first reported a position in Exelixis in Q2 2019 and has held it in 11 quarters since.
  • Fieldpoint Private Securities's Exelixis position peaked at $378K in Q4 2019.
  • 375 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.